SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
rsv
Journals
7
1
Applied and environmental microbiology
2
Viruses
3
The New England journal of medicine
4
Journal of virological methods
5
Journal of medical virology
6
investigative ophthalmology & visual science
7
journal of the pediatric infectious diseases society
Research Groups
0
No Research Group Connected
Bibliographies
47
1
Pathogenesis of Respiratory Syncytial Virus Infection in BALB/c Mice Differs Between Intratracheal and Intranasal Inoculation.
2
Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
3
Multiple Respiratory Syncytial Virus Introductions Into a Neonatal Intensive Care Unit.
4
Whole genome comparisons of isolates from cattle and chickens.
5
rsv fusion: time for a new model
6
A Novel Dual and Triple Shifted RSVP Paradigm for P300 Speller.
7
Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series.
8
Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
9
Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data.
10
Correction to: Blocking of opioid receptors in experimental formaline-inactivated respiratory syncytial virus (FI-RSV) immunopathogenesis: from beneficial to harmful impacts (Medical Microbiology and Immunology, (2018), 207, 2, (105-115), 10.1007/s00430-017-0531-0)
11
Pooled Sequencing of Candidate Genes Implicates Rare Variants in the Development of Asthma Following Severe RSV Bronchiolitis in Infancy.
12
PBMC transcriptome profiles identifies potential candidate genes and functional networks controlling the innate and the adaptive immune response to PRRSV vaccine in Pietrain pig.
13
Comparison of the Transcriptome Response within the Swine Tracheobronchial Lymphnode Following Infection with PRRSV, PCV-2 or IAV-S.
14
In silico structure-based design and synthesis of novel anti-RSV compounds.
15
Disease severity of respiratory syncytial virus (RSV) infection correlate to a novel set of five amino acid substitutions in the RSV attachment glycoprotein (G) in China.
16
Analysis of the Binding Sites of Porcine Sialoadhesin Receptor with PRRSV
17
The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years
18
Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived.
19
Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses.
20
Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses
21
Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies.
22
RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA.
23
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults
24
Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice
25
Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived
26
Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization
27
Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies
28
Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant
29
Severe RSV bronchiolitis in an immunocompromised child
30
Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication
31
Testing models predicting severity of respiratory syncytial virus infection on the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada
32
RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA
33
Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement
34
An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines
35
Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database
36
Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice.
37
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group
38
Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant
39
efficacy evaluation of two commercial vaccines against a recombinant prrsv2 strain zjnb16-2 from lineage 8 and 3 in china
40
concurrent memory load can make rsvp search more efficient
41
isolation and characterisation of prsv-p resistance genes in carica and vasconcellea
42
the role of rsv infection in asthma initiation and progression: findings in a mouse model
43
pesquisa de anticorpos anti-neospora spp. e anti-herpersvírus equino em cavalos de tração no município de santa maria, rs, brasil looking for antibodies anti-neospora spp. and anti-equine herpersvirus in carter horses in santa maria, brazil
44
time series analysis of rsv and bronchiolitis seasonality in temperate and tropical western australia
45
kursvärderingar i system – akademiska lärares upplevelser och organisationens förmåga till utveckling
46
targeted delivery of gp5 antigen of prrsv to m cells enhances the antigen-specific systemic and mucosal immune responses
47
Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis
×
SciMatic on Your Phone
Track your articles, view certificates, and stay updated — anywhere, anytime.
Google Play